Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCHAMPIONS ONCOLOGY, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CHAMPIONS ONCOLOGY, INC.

$4.84Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q3 ’2620172018201920202021202220232024202505M10M15MLatest period Q1 '27. Revenue 15.23M. Gross profit 7.7M. Net profit -426K.
RevenueGross profitNet profit
See which business lines, products, or regions generate the company’s sales.Formula: Company revenue = Σ(segment revenues) + reconciliation adjustments
Q3 ’2620172018201920202021202220232024202505M10M15MLatest period Q1 '27. Pharmacology Services 14.16M. Product And Service Other 183K. Translational Oncology Solutions TOS License Revenue 893K.
Personalized Oncology ServicesPharmacology ServicesProduct And Service OtherTranslational Oncology Solutions TOS License Revenue
See how much of the company’s revenue comes from each customer it reports as 10% or more of revenue. Filings often name these customers only as Customer A, Customer B, and so on.Formula: Customer share = customer revenue ÷ total revenue × 100% Other customers = 100% − Σ(major customer shares)
Q1 ’212017201820192020202220232024202520260%20%40%60%80%100%
      Latest period Q3 '21. Pharmaceutical Services And Other TOS Customer 10%. Other customers 90%.
      Pharmaceutical Services And Other TOS CustomerOther customers
      See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
      Q3 ’26201720182019202020212022202320242025-50%0%50%100%Latest period Q1 '27. Gross margin 50.5%. Operating margin -2.7%. Net profit margin -2.8%.
      Gross marginOperating marginNet profit margin
      See the amounts the company has committed to pay that its balance sheet does not record yet: leases it has signed that have not started, unconditional purchase and other contractual commitments, and the most it could have to pay under guarantees and credit backstops. Amounts are as the filing reports them at each balance-sheet date.Formula: Commitments = leases not yet commenced + purchase & other commitments + maximum guarantee exposure
      Q3 ’262017201820192020202120222023202420250100K200K300K400K
          Latest period Q1 '27. Purchase & other commitments 469K.
          Leases not yet commencedPurchase & other commitmentsGuarantees & contingent commitments
          Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
          $
          Q3 ’26201720182019202020212022202320242025-4M-2M02M4M6M
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            Latest period Q1 '27. Operating cash flow -492K. Capex -55K. Free cash flow -547K.
            Operating cash flowCapexFree cash flow
            Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
            202620172018201920202021202220232024202502M4M6M8M10M
                Latest period 2027. Cash 4.4M. Debt 0.
                CashDebtNet cash
                Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
                $/share
                Q3 ’26201720182019202020212022202320242025-1.000.001.00
                  • Earnings period 2016-11-01 to 2017-01-31. Shares as of 2017-01-31: 10,967,491 source shares.
                  • Earnings period 2016-05-01 to 2017-04-30. Shares as of 2017-04-30: 10,982,159 source shares.
                  • Earnings period 2017-05-01 to 2017-07-31. Shares as of 2017-07-31: 10,982,159 source shares.
                  • Earnings period 2017-08-01 to 2017-10-31. Shares as of 2017-10-31: 10,988,347 source shares.
                  • Earnings period 2017-11-01 to 2018-01-31. Shares as of 2018-01-31: 11,000,847 source shares.
                  • Earnings period 2017-05-01 to 2018-04-30. Shares as of 2018-04-30: 11,003,228 source shares.
                  • Earnings period 2018-05-01 to 2018-07-31. Shares as of 2018-07-31: 11,027,990 source shares.
                  • Earnings period 2018-08-01 to 2018-10-31. Shares as of 2018-10-31: 11,474,805 source shares.
                  • Earnings period 2018-11-01 to 2019-01-31. Shares as of 2019-01-31: 11,612,700 source shares.
                  • Earnings period 2018-05-01 to 2019-04-30. Shares as of 2019-04-30: 11,619,538 source shares.
                  • Earnings period 2019-05-01 to 2019-07-31. Shares as of 2019-07-31: 11,619,538 source shares.
                  • Earnings period 2019-08-01 to 2019-10-31. Shares as of 2019-10-31: 11,620,163 source shares.
                  • Earnings period 2019-11-01 to 2020-01-31. Shares as of 2020-01-31: 11,619,538 source shares.
                  • Earnings period 2019-05-01 to 2020-04-30. Shares as of 2020-04-30: 12,726,728 source shares.
                  • Earnings period 2020-05-01 to 2020-07-31. Shares as of 2020-07-31: 12,727,888 source shares.
                  • Earnings period 2020-08-01 to 2020-10-31. Shares as of 2020-10-31: 13,368,545 source shares.
                  • Earnings period 2020-11-01 to 2021-01-31. Shares as of 2021-01-31: 13,390,172 source shares.
                  • Earnings period 2020-05-01 to 2021-04-30. Shares as of 2021-04-30: 13,414,066 source shares.
                  • Earnings period 2021-05-01 to 2021-07-31. Shares as of 2021-07-31: 13,415,066 source shares.
                  • Earnings period 2021-08-01 to 2021-10-31. Shares as of 2021-10-31: 13,496,144 source shares.
                  • Earnings period 2021-11-01 to 2022-01-31. Shares as of 2022-01-31: 13,517,941 source shares.
                  • Earnings period 2021-05-01 to 2022-04-30. Shares as of 2022-04-30: 13,522,441 source shares.
                  • Earnings period 2022-05-01 to 2022-07-31. Shares as of 2022-07-31: 13,522,441 source shares.
                  • Earnings period 2022-08-01 to 2022-10-31. Shares as of 2022-10-31: 13,558,650 source shares.
                  • Earnings period 2022-11-01 to 2023-01-31. Shares as of 2023-01-31: 13,558,650 source shares.
                  • Earnings period 2022-05-01 to 2023-04-30. Shares as of 2023-04-30: 13,544,228 source shares.
                  • Earnings period 2023-05-01 to 2023-07-31. Shares as of 2023-07-31: 13,484,110 source shares.
                  • Earnings period 2023-08-01 to 2023-10-31. Shares as of 2023-10-31: 13,593,766 source shares.
                  • Earnings period 2023-11-01 to 2024-01-31. Shares as of 2024-01-31: 13,593,766 source shares.
                  • Earnings period 2023-05-01 to 2024-04-30. Shares as of 2024-04-30: 13,593,766 source shares.
                  • Earnings period 2024-05-01 to 2024-07-31. Shares as of 2024-07-31: 13,593,766 source shares.
                  • Earnings period 2024-08-01 to 2024-10-31. Shares as of 2024-10-31: 13,698,903 source shares.
                  • Earnings period 2024-11-01 to 2025-01-31. Shares as of 2025-01-31: 13,705,570 source shares.
                  • Earnings period 2024-05-01 to 2025-04-30. Shares as of 2025-04-30: 13,777,170 source shares.
                  • Earnings period 2025-05-01 to 2025-07-31. Shares as of 2025-07-31: 13,788,421 source shares.
                  • Earnings period 2025-08-01 to 2025-10-31. Shares as of 2025-10-31: 13,886,326 source shares.
                  • Earnings period 2025-11-01 to 2026-01-31. Shares as of 2026-01-31: 13,886,826 source shares.
                  • Earnings period 2025-05-01 to 2026-04-30. Shares as of 2026-04-30: 13,886,826 source shares.
                  • Earnings period 2026-05-01 to 2026-07-31. Shares as of 2026-07-31: 13,918,569 source shares.
                  Latest period Q1 2027. EPS (TTM) -0.08.
                  EPS (TTM)
                  How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
                  Q3 ’262017201820192020202120222023202420250x1,000x2,000x3,000x
                    • Earnings period 2016-11-01 to 2017-01-31. Shares as of 2017-01-31: 10,967,491 source shares. Nearby weekly price on 2017-02-03.
                    • Earnings period 2016-05-01 to 2017-04-30. Shares as of 2017-04-30: 10,982,159 source shares. Nearby weekly price on 2017-04-28.
                    • Earnings period 2017-05-01 to 2017-07-31. Shares as of 2017-07-31: 10,982,159 source shares. Nearby weekly price on 2017-07-28.
                    • Earnings period 2017-08-01 to 2017-10-31. Shares as of 2017-10-31: 10,988,347 source shares. Nearby weekly price on 2017-11-03.
                    • Earnings period 2017-11-01 to 2018-01-31. Shares as of 2018-01-31: 11,000,847 source shares. Nearby weekly price on 2018-02-02.
                    • Earnings period 2017-05-01 to 2018-04-30. Shares as of 2018-04-30: 11,003,228 source shares. Nearby weekly price on 2018-04-27.
                    • Earnings period 2018-05-01 to 2018-07-31. Shares as of 2018-07-31: 11,027,990 source shares. Nearby weekly price on 2018-08-03.
                    • Earnings period 2018-08-01 to 2018-10-31. Shares as of 2018-10-31: 11,474,805 source shares. Nearby weekly price on 2018-11-02.
                    • Earnings period 2018-11-01 to 2019-01-31. Shares as of 2019-01-31: 11,612,700 source shares. Nearby weekly price on 2019-02-01.
                    • Earnings period 2018-05-01 to 2019-04-30. Shares as of 2019-04-30: 11,619,538 source shares. Nearby weekly price on 2019-05-03.
                    • Earnings period 2019-05-01 to 2019-07-31. Shares as of 2019-07-31: 11,619,538 source shares. Nearby weekly price on 2019-08-02.
                    • Earnings period 2019-08-01 to 2019-10-31. Shares as of 2019-10-31: 11,620,163 source shares. Nearby weekly price on 2019-11-01.
                    • Earnings period 2019-11-01 to 2020-01-31. Shares as of 2020-01-31: 11,619,538 source shares. Weekly price on 2020-01-31.
                    • Earnings period 2019-05-01 to 2020-04-30. Shares as of 2020-04-30: 12,726,728 source shares. Nearby weekly price on 2020-05-01.
                    • Earnings period 2020-05-01 to 2020-07-31. Shares as of 2020-07-31: 12,727,888 source shares. Weekly price on 2020-07-31.
                    • Earnings period 2020-08-01 to 2020-10-31. Shares as of 2020-10-31: 13,368,545 source shares. Nearby weekly price on 2020-10-30.
                    • Earnings period 2020-11-01 to 2021-01-31. Shares as of 2021-01-31: 13,390,172 source shares. Nearby weekly price on 2021-01-29.
                    • Earnings period 2020-05-01 to 2021-04-30. Shares as of 2021-04-30: 13,414,066 source shares. Weekly price on 2021-04-30.
                    • Earnings period 2021-05-01 to 2021-07-31. Shares as of 2021-07-31: 13,415,066 source shares. Nearby weekly price on 2021-07-30.
                    • Earnings period 2021-08-01 to 2021-10-31. Shares as of 2021-10-31: 13,496,144 source shares. Nearby weekly price on 2021-10-29.
                    • Earnings period 2021-11-01 to 2022-01-31. Shares as of 2022-01-31: 13,517,941 source shares. Nearby weekly price on 2022-01-28.
                    • Earnings period 2021-05-01 to 2022-04-30. Shares as of 2022-04-30: 13,522,441 source shares. Nearby weekly price on 2022-04-29.
                    • Earnings period 2022-05-01 to 2022-07-31. Shares as of 2022-07-31: 13,522,441 source shares. Nearby weekly price on 2022-07-29.
                    • Earnings period 2022-08-01 to 2022-10-31. Shares as of 2022-10-31: 13,558,650 source shares. Nearby weekly price on 2022-10-28.
                    • Earnings period 2022-11-01 to 2023-01-31. Shares as of 2023-01-31: 13,558,650 source shares. Nearby weekly price on 2023-02-03.
                    • Earnings period 2022-05-01 to 2023-04-30. Shares as of 2023-04-30: 13,544,228 source shares. Nearby weekly price on 2023-04-28.
                    • Earnings period 2023-05-01 to 2023-07-31. Shares as of 2023-07-31: 13,484,110 source shares. Nearby weekly price on 2023-07-28.
                    • Earnings period 2023-08-01 to 2023-10-31. Shares as of 2023-10-31: 13,593,766 source shares. Nearby weekly price on 2023-11-03.
                    • Earnings period 2023-11-01 to 2024-01-31. Shares as of 2024-01-31: 13,593,766 source shares. Nearby weekly price on 2024-02-02.
                    • Earnings period 2023-05-01 to 2024-04-30. Shares as of 2024-04-30: 13,593,766 source shares. Nearby weekly price on 2024-05-03.
                    • Earnings period 2024-05-01 to 2024-07-31. Shares as of 2024-07-31: 13,593,766 source shares. Nearby weekly price on 2024-08-02.
                    • Earnings period 2024-08-01 to 2024-10-31. Shares as of 2024-10-31: 13,698,903 source shares. Nearby weekly price on 2024-11-01.
                    • Earnings period 2024-11-01 to 2025-01-31. Shares as of 2025-01-31: 13,705,570 source shares. Weekly price on 2025-01-31.
                    • Earnings period 2024-05-01 to 2025-04-30. Shares as of 2025-04-30: 13,777,170 source shares. Nearby weekly price on 2025-05-02.
                    • Earnings period 2025-05-01 to 2025-07-31. Shares as of 2025-07-31: 13,788,421 source shares. Nearby weekly price on 2025-08-01.
                    • Earnings period 2025-08-01 to 2025-10-31. Shares as of 2025-10-31: 13,886,326 source shares. Weekly price on 2025-10-31.
                    • Earnings period 2025-11-01 to 2026-01-31. Shares as of 2026-01-31: 13,886,826 source shares. Nearby weekly price on 2026-01-30.
                    • Earnings period 2025-05-01 to 2026-04-30. Shares as of 2026-04-30: 13,886,826 source shares. Nearby weekly price on 2026-05-01.
                    • Earnings period 2026-05-01 to 2026-07-31. Shares as of 2026-07-31: 13,918,569 source shares. Weekly price on 2026-07-31.
                    Latest period Q1 2027. P/E ratio -67.6x.
                    P/E ratio
                    See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
                    202620172018201920202021202220232024202505M10M
                        Latest period 2027. Shares outstanding 13.9M. Class detail unavailable 13.9M.
                        Class detail unavailable